Abstract

Objective: The present study was designed to test the level of some cardiac hormones like endothelin-1 and Atrial natriuretic peptide (ANP) in serum of heart diseases patients compare with control group. This study was conducted on heart diseases patients in Cardiac Care Unit (C.C.U.) in Salah- Aldin General Hospital in Tikrit City-Salah-Aldin governorate. The study, began in 31 Desember 2018 to 1 st September 2019 and included 90 subjects divided in two groups ,the first group was (10) apparently healthy subjects10 male and 10 female, while the second group was 80 patients with different heart diseases (20 Heart Failure (HF) 10 male and 10 female, 20 Myocardial Infarction (MI) 10 male and 10 female, 20 Unstable Angina (UA) 10 male and 10 female, 20 Stable Angina (SA) 10 male and 10 female, were attended from Salah - Aldin General Hospital. Blood samples was collected from patients and healthy subjects and then serum separated for testing. The results of this study showed there were a high significant increasing ( P≤ 0.01) in the concentration of endothelin-1 and Atrial natriuretic peptide (ANP) in all Heart disease groups as compared with control healthy subjects and the highest concentration of endothelin-1 was found in heart failure group, while the highest concentration of ANP was found in myocardial infarction group. Material and methods: Venous blood samples were collected from the vein from all patients and healthy subjects at study entry and after a 20-min period and serum was separated by centrifugation at 1500 g for 10 min at 4 Cfor hormonal testing. Endothelin-1and Atrial natriuretic peptide (ANP) hormones concentration in serum of heart diseases patients was estimated depends on kit procedure is an Enzyme-Linked Immunosorbent Assay (ELISA) from Bioassay Technology, China. Results: There was a high significant increasing ( P≤ 0.01) in the concentration of endothelin-1 in all heart disease groups as compared with control healthy subjects and the highest concentration of endothelin-1 was found in heart failure group, ANP There was a high significant increasing ( P≤ 0.01) in the concentration of ANP in all Heart disease groups as compared with control healthy subjects ,the highest concentration of (ANP ng/ml) was found in Myocardial infarction group. Conclusion: Serum endothelin-1 and Atrial natriuretic peptide (ANP) hormone concentration were significantly increased (P≤ 0.01) in all Heart diseases groups as compared with control healthy subjects. This finding suggests that endothelin may be a marker of rapid coronary artery disease progression and may also have a pathogenic role in this process.

References

  • Abdul Kareem ,M.Kh. (2012).The Role and Correlation of Interleukin -8 and Interleukin-10 in Iraqi Patients with acute coronary syndrome. Baghdad university, collage of medicine, Dep, Pathology/immunology and microbiology, Board thesis.
  • AL Azzawy, RQ. (2018). Physiological, chemical and hormonal changes for a number of heart diseases in Kirkuk Governorate . master Thesis، college of Education for Women . University of Tikrit.
  • Böhm, F.; Pernow, J. (2007). ”The importance of endothelin -1 for vascular dysfunction in cardiovascular disease” (PDF). Cardiovascular Research. 76 (1):8–18.
  • Buglioni, A.; Cannone, V.; Cataliotti, A.; Sangaralingham, S.J.; Heublein, D.M.; Scott, C.G. et al.(2015). Circulating aldosterone and natriuretic peptides in the general community: Relationship to cardiorenal and metabolic disease. Hypertension . 65, 45–53
  • Cannone, V., Cabassi, A., Volpi, R., & Burnett, J. C. (2019). Atrial natriuretic peptide: A molecular target of novel therapeutic approaches to cardio-metabolic disease. .‏ Int. J. Mol. Sci. 2019, 20, 3265.
  • Cannone, V.; Buglioni, A.; Sangaralingham, S.J.; Scott, C.; Bailey, K.R.; Rodeheer, R. (2018). Aldosterone, hypertension, and antihypertensive therapy: Ifrom a general population. Mayo. Clin. Proc. 93, 980–990.
  • Coue, M.; Moro, C.(2016). Natriuretic peptide control of energy balance and glucose homeostasis. Biochimie . 124, 84–91.
  • Davenport, AP.; Hyndman, KA.; Dhaun, N.; Southan, C.; Kohan, DE.;Pollock,JS.(2016). ”Endothelin”. PharmacologicalReviews. 68(2):357418.
  • Eitel, I.; Nowak, M.; Stehl, C.; Adams, V.; Fuernau, G.; Hildebrand, L. (2010) . Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and noreflow assessed by contrast-enhanced magnetic resonance imaging. Am Heart J .159:882–90.
  • Garbers, D.L.; Chrisman, T.D.;Wiegn, P.; Katafuchi, T.; Albanesi, J.P.; Bielinski, V. et al. (2006) . Membrane guanylyl cyclase receptors: An update. Trends Endocrinol. Metab. 17, 251–258.
  • Goodfriend, T.L.; Calhoun, D.A.(2004). Resistant hypertension, obesity, sleep apnea, and aldosterone: Theory and therapy. Hypertension . 43, 518–524.
  • Gupta, RM.; Hadaya, J.; Trehan, A.; Zekavat, SM.; Roselli, C.; Klarin, D. (2017). A genetic variant associated with five vascular diseases is a distal regulator of endothelin-1 gene expression. Cell .170:522–33.e15.
  • Ibrahim, N. E.; Gupta, R.; Lyass, A.; Li, Y.; Shrestha, S.; McCarthy, C. P., ... & Januzzi Jr, J. L. (2018). Endothelin-1 measurement in patients undergoing diagnostic coronary angiography—results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study. Clinical chemistry, 64(11), 1617-1625.‏
  • Jankowich, MD.; Wu, W.; Choudhary, G.(2016). Association of elevated plasma endothelin-1 levels with pulmonary hypertension, mortality, and heart failure in African American individuals: the Jackson Heart Study. JAMA Cardiol .1:461–9.
  • Kawanabe, Y.; Nauli, SM. (January 2011). ”Endothelin”. Cellular and Molecular Life Sciences. 68 (2): 195–203.
  • Libby P.(1995). The molecular bases of acute coronary syndromes. Circulation 91: 2844–50.
  • Macheret, F.; Heublein, D.; Costello-Boerrigter, L.C.; Boerrigter, G.; McKie, P.; Bellavia, D. et al.(2012). Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP. J. Am. Coll. Cardiol. 60, 1558–1565.
  • Maguire, JJ.; Davenport, AP. (2014). ”Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12”. British Journal of Pharmacology. 171 (24): 5555–72.
  • Mawji, IA.; Robb, GB.; Tai, SC.; Marsden, PA. (2004). “Role of the 3’-untranslated region of human endothelin-1 in vascular endothelial cells. Contribution to transcript lability and the cellular heat shock response”. The Journal of Biological Chemistry. 279 (10): 8655–67.
  • Nyaika, J. A., Njoloma, J. P., Zimba, S., Mwase, W. F., Maliro, M. F., Bokosi, J. M., & Kwapata, M. B. (2014). The Effectiveness of Repeated Shoot Tip Culture on Pathogens Load Reduction in Different Local Potato Genotypes in Malawi. The International Journal of Biotechnology, 3(7), 91-103.
  • Radico, F.; Cicchitti, V.; Zimarino, M. and De Caterina, R. (2014). Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests. JACC: Cardiovascular Interventions, 7(5): 453-463.
  • Sanchis-Gomar, F.; Perez-Quilis, C.; Leischik, R., and Lucia, A. (2016). Epidemiology of coronary heart disease and acute coronarysyndrome. Annals of translational medicine, 4(13): 256.
  • Schinelli, S. (2006). Pharmacology and physiopathology of the brain endothelin system: an overview . Current Medicinal Chemistry. 13 (6): 627–38.
  • Sullivan, D. (2018). Everything you need to know about heart disease on February 7, 2018.
  • Tang, WHW.; Shrestha, K.; Martin, MG.; Borowski, AG.; Jasper, S.; Yandle, TG. (2010). Clinical significance of endogenous vasoactive neurohormones in chronic systolic heart failure. J Card Fail 16:635– 40.
  • Volpe, M.; Carnovali, M.; Mastromarino, V. (2016) .The natriuretic peptides system in the pathophysiology of heart failure: From molecular basis to treatment. Clin. Sci. (Lond.) 130, 57–77.
  • Zouridakis, EG.; Schwartzman, R.; Garcia-Moll, X.; Cox, ID.; Fredericks, S.; Holt, D. W., & Kaski, J. C. (2001). Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression. European heart journal, 22(17), 1578-1584.‏

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.